Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sanjaykumar Bari"'
Autor:
Kirti Rajput, Shraddha Tawade, Sopan Nangare, Nitin Shirsath, Sanjaykumar Bari, Laxmikant Zawar
Publikováno v:
International Journal of Biological Macromolecules. 222:915-926
Low methoxy pectin (LM pectin) suffers from burst release owing to its high swellability and solubility in water. Consequently, in ways to design an ideal drug delivery system, these obstacles must be surmounted. Therefore, the work aimed to design d
Publikováno v:
Journal of Pharmaceutical Research International. :617-632
Aims: In this study was two noteworthy pharmacophores quinazolin-4(3H)-one and 1,3,4-thiadiazole through methylene bridge were utilized to design, synthesize and characterize some novel 2-methyl quinazolin-4(3H)-one and 6-chloro-2-methyl quinazolin-4
Autor:
Vishal Gurumukhi, Vivek Sonawane, Ganesh Tapadiya, Sanjaykumar Bari, Sanjay Surana, Sailesh Subhashrao Chalikwar
Publikováno v:
SSRN Electronic Journal.
Autor:
Vishal Gurumukhi, Sanjaykumar Bari
The objective of the present work was to optimize ritonavir (RTV) loaded nanostructured lipid carriers (NLCs) to improve bioavailability using quality by design (QbD) based technique. Risk assessment was studied using ‘cause and effect’ diagram f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ac36b9d8133a6092bbab00c84cff6d
https://doi.org/10.21203/rs.3.rs-695187/v1
https://doi.org/10.21203/rs.3.rs-695187/v1
Autor:
Vishal Gurumukhi, Sanjaykumar Bari
Atazanavir (ATV) is widely used as anti-HIV agent with poor aqueous solubility which requires fabrication of novel drug delivery system to enhance therapeutic activity and safety. For this purpose, the quality by design (QbD) based ATV loaded nanostr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdf90577e38cde884030812173c56163
https://doi.org/10.21203/rs.3.rs-198073/v1
https://doi.org/10.21203/rs.3.rs-198073/v1
Autor:
Srikanth Racharla, Sanjay J. Surana, Sandeep B. Shelar, Sanjaykumar Bari, Mangesh Ghodke, Prashant Jagannath Chaudhari, Sharad Wakode, Atul A. Shirkhedkar, Vinod G. Ugale
Publikováno v:
Journal of Molecular Structure. 1247:131280
This review focuses on the potential of indolin-2-one in the treatment of cancer as a chemotherapeutic nucleus and highlights significant recent progress in the synthetic development of indolin-2-one as an antitumor agent. The indolin-2-one framework